Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Making Emergency Artery Repairs Safer

By HospiMedica staff writers
Posted on 18 Dec 2007
A new study has found that state-of-the-art treatment is making the repair of catheter-related vessel puncture and ruptures during angioplasty less risky.

Researchers from the University of California Davis Medical Center (UCDMC, USA) conducted a review of literature on vessel rupture and perforation: important complications of percutaneous treatment of coronary and peripheral arterial disease. More...
The researchers stressed that these complications could result in abrupt vessel closure, distal organ injury, bleeding into the surrounding tissue, and death. The researchers found that an estimated 0.1% of patients undergoing balloon angioplasty suffered a perforation during the procedure; patients treated with a rotablator drill had a 1.3% risk of perforation, while those treated with the excimer laser faced a 1.9% risk.

Prompt management of such complications is critically important. The review describes the management of vessel rupture and perforation, including the use of different types of covered stents (balloon-expandable and self-expanding), as well as the various types of embolization coils. Following a puncture, the researchers first recommend inflating a balloon at the site to stem the bleeding. Then they suggest inserting embolization coils or a flexible stent graft to repair the vessel. Suggested treatment also involves subsequent drug therapy to promote clotting. The review was published on November 13, 2007, as an online early article in the Journal of Interventional Cardiology.

"Rupture or perforation of a blood vessel during angioplasty can result in life-threatening bleeding,” said lead author John R. Laird, M.D., of the division of cardiovascular medicine at UCDMC. "This review provides doctors with a summary of equipment and techniques that will enhance their ability to treat such complications.”


Related Links:
University of California Davis Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.